Surya Imaging And Pathology Centre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-07-2024
- Paid Up Capital ₹ 0.10 M
as on 15-07-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 50.59%
(FY 2022)
- Profit 149.16%
(FY 2022)
- Ebitda -0.73%
(FY 2022)
- Net Worth 3.26%
(FY 2022)
- Total Assets -3.66%
(FY 2022)
About Surya Imaging And Pathology Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bindu Devi, Kuldip Singh, and Shyam Talwar serve as directors at the Company.
- CIN/LLPIN
U85110DL2004PTC130690
- Company No.
130690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surya Imaging And Pathology Centre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bindu Devi  | Director | 22-Nov-2004 | Current |
| Kuldip Singh | Director | 22-Nov-2006 | Current |
| Shyam Talwar | Director | 28-Aug-2010 | Current |
Financial Performance of Surya Imaging And Pathology Centre.
Surya Imaging And Pathology Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.59% increase. The company also saw a substantial improvement in profitability, with a 149.16% increase in profit. The company's net worth moved up by a moderate rise of 3.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Imaging And Pathology Centre?
In 2020, Surya Imaging And Pathology Centre had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Diagnostic Bazar E-Solution Private LimitedActive 4 years 6 monthsBindu Devi and Kuldip Singh are mutual person
Orbit Imaging And Pathlab Private LimitedActive 20 years 11 daysBindu Devi and Kuldip Singh are mutual person
- Shubhaarambh Educational Services Private LimitedActive 1 year 2 months
Bindu Devi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Surya Imaging And Pathology Centre?
Unlock and access historical data on people associated with Surya Imaging And Pathology Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Imaging And Pathology Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Imaging And Pathology Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
